First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.62 HKD 1.64% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
VIVA Biotech Holdings

There are no price targets for VIVA Biotech Holdings.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
VIVA Biotech Holdings Competitors:
Price Targets
GSS
Genetic Signatures Ltd
9% Upside
DCAL
Dishman Carbogen Amcis Ltd
28% Downside
PIQ
Proteomics International Laboratories Ltd
34% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
GSS
Genetic Signatures Ltd
9% Upside
DCAL
Dishman Carbogen Amcis Ltd
28% Downside
PIQ
Proteomics International Laboratories Ltd
34% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
O
OABI
OmniAb Inc
122% Upside
I
300030
Improve Medical Instruments Co Ltd
189% Upside
DXRX
Diaceutics PLC
71% Upside
DIVISLAB
Divi's Laboratories Ltd
14% Downside

Revenue
Forecast

Revenue Estimate
VIVA Biotech Holdings

For the last 6 years the compound annual growth rate for VIVA Biotech Holdings's revenue is 56%. The projected CAGR for the next 2 years is 26%.

56%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
VIVA Biotech Holdings

For the last 6 years the compound annual growth rate for VIVA Biotech Holdings's operating income is 24%. The projected CAGR for the next 2 years is 52%.

24%
Past Growth
52%
Estimated Growth
Estimates Accuracy
-43%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
VIVA Biotech Holdings

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIVA Biotech Holdings's stock price target?
Not Available

VIVA Biotech Holdings doesn't have any price targets made by Wall Street professionals.

What is VIVA Biotech Holdings's Revenue forecast?
Projected CAGR
26%

For the last 6 years the compound annual growth rate for VIVA Biotech Holdings's revenue is 56%. The projected CAGR for the next 2 years is 26%.

What is VIVA Biotech Holdings's Operating Income forecast?
Projected CAGR
52%

For the last 6 years the compound annual growth rate for VIVA Biotech Holdings's operating income is 24%. The projected CAGR for the next 2 years is 52%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.